Pediatric Cancer Immunotherapy Working Group


To promote career development of physician-scientists and develop new investigator-initiated immunotherapies while bolstering the submission/securement of pediatric immunotherapy focused program project grants and core resources within veterinary comparative oncology and bioengineering.

A young boy is indoors in a hospital. He has cancer, and his head is shaved. He is smiling while talking with his female doctor and having his heartbeat checked.

Given the dearth of pediatric, adolescent and young adult cancer immunotherapies for high-risk malignancies (e.g., relapsed/refractory extra-cranial solid tumors, CNS malignancies and AML), the Cancer Center spearheaded the formation of the Pediatric Cancer Immunotherapy Working Group (PCI2) in 2019 to link trainees and/or junior faculty with established investigators to foster career development while enhancing catalysis of pediatric/AYA specific immunotherapies.


For more information about the group, please contact Elias Sayour, M.D., Ph.D.

Elias Sayour

Elias Sayour MD, PhD

Stop Children's Cancer/Bonnie R. Freeman Professor For Pediatric Oncology Research; Assistant Dean
Phone: (352) 273-9000

NCI Cancer Center badge